Constantine Davides
Stock Analyst at Citizens
(1.05)
# 3,912
Out of 5,139 analysts
118
Total ratings
31.19%
Success rate
-20.09%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $36.03 | +5.47% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $3.77 | +165.25% | 12 | Jan 6, 2026 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $24 → $22 | $19.02 | +15.67% | 13 | Dec 19, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $85.37 | +42.91% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $23.33 | +32.88% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $12.15 | +97.53% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $30.27 | +58.57% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $107.51 | +39.53% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $20.33 | - | 2 | Jun 18, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $9.51 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $1.02 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $86.00 | +31.40% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $31.02 | -16.18% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $183.57 | +35.10% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $21.81 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $9.16 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.52 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.18 | +344.92% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.55 | +22,544.93% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $27.83 | -46.10% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $19.44 | +15.74% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $2.90 | +193.10% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.04 | +1,246.15% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $1.38 | +25,986.96% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.78 | +181,922.47% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.93 | +4,221.05% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.29 | +1,946.38% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.21 | +66,290.04% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $0.45 | +1,099,237.75% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.38 | +22,198.01% | 2 | Sep 23, 2022 |
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $36.03
Upside: +5.47%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $3.77
Upside: +165.25%
AMN Healthcare Services
Dec 19, 2025
Maintains: Market Outperform
Price Target: $24 → $22
Current: $19.02
Upside: +15.67%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $85.37
Upside: +42.91%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $23.33
Upside: +32.88%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $12.15
Upside: +97.53%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $30.27
Upside: +58.57%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $107.51
Upside: +39.53%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $20.33
Upside: -
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.51
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $1.02
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $86.00
Upside: +31.40%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $31.02
Upside: -16.18%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $183.57
Upside: +35.10%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $21.81
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.16
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $24.52
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.18
Upside: +344.92%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.55
Upside: +22,544.93%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $27.83
Upside: -46.10%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $19.44
Upside: +15.74%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $2.90
Upside: +193.10%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.04
Upside: +1,246.15%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $1.38
Upside: +25,986.96%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.78
Upside: +181,922.47%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.93
Upside: +4,221.05%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.29
Upside: +1,946.38%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.21
Upside: +66,290.04%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $0.45
Upside: +1,099,237.75%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.38
Upside: +22,198.01%